Heart disease mitigated by ventricular assist device

What Is a Ventricular Assist Device?

A ventricular assist device, commonly called a VAD, is a mechanical pump implanted in the chest to help a failing heart move blood through the body. Unlike a total artificial heart, a VAD does not replace the heart itself. Instead, it works alongside the native organ, taking over much of the pumping work when the heart’s own muscle can no longer generate enough force on its own.¹

Most devices used today are left ventricular assist devices, or LVADs, since the left ventricle is the chamber most commonly weakened by advanced heart failure. An inflow cannula draws blood from the left ventricle into the pump, and an outflow cannula returns that blood to the aorta, restoring circulation to the rest of the body.¹

VADs are reserved for people with advanced heart failure whose symptoms persist despite maximum medical therapy. For these patients, a VAD can mean the difference between a severely limited life and a return to daily activity, whether the device serves as a bridge to heart transplant, a long term destination therapy, or, in a smaller number of cases, a bridge to recovery of the heart’s own function.²

The use of ventricular assist devices improves the rate of survival, quality of life, and functional capacity in patients with advanced heart failure.
National Center for Biotechnology Information

How Does a Ventricular Assist Device Work?

Modern VADs use continuous flow technology rather than the pulsatile, balloon like pumping of earlier generation devices. A small rotor spins at very high speed inside the pump housing, moving blood steadily rather than in the rhythmic beats produced by a natural heart.¹

The most advanced systems, such as the HeartMate 3, use full magnetic levitation to suspend the rotor within the pump without any mechanical bearings touching it. This design reduces friction and mechanical wear, and it also creates wider blood flow pathways that lower the risk of clot formation inside the device itself.¹

Power reaches the implanted pump through a driveline, a cable that passes through the skin and connects to an external controller and battery pack that patients wear on a belt or in a small bag. The controller monitors pump speed and flow continuously and alerts the patient or care team if something requires attention.²

Who Needs a Ventricular Assist Device?

VAD candidates typically have advanced heart failure that has not responded adequately to medication, lifestyle changes, or less invasive interventions. Common qualifying conditions include severe dilated cardiomyopathy, ischemic heart disease with significant loss of pumping function, and end stage heart failure with persistent symptoms such as breathlessness, fatigue, and inability to tolerate physical activity.³

Physicians generally place candidates into one of three categories. Bridge to transplant patients receive a VAD while waiting for a suitable donor heart to become available. Destination therapy patients are not eligible for transplant, often due to age or other medical conditions, and receive the VAD as a long term treatment in its own right. Bridge to recovery patients receive temporary support while their own heart muscle heals, occasionally allowing the device to be removed later.²

A thorough medical evaluation precedes implantation, assessing heart function, kidney and liver health, nutritional status, and the patient’s ability to manage the device and its equipment at home. Psychological readiness and a strong support system at home are also weighed carefully, since living with a VAD requires daily engagement with the equipment.³

The Implantation Procedure

VAD implantation is major open heart surgery, typically performed with the patient on cardiopulmonary bypass. The surgeon places the pump either beside the heart or, with some newer compact devices, directly within the pericardial space, then connects the inflow and outflow cannulas to the left ventricle and aorta.¹

The driveline is tunneled beneath the skin and exits through a small incision, usually on the abdomen, where it connects to the external controller and power source. Surgery generally requires several hours, followed by recovery in an intensive care setting and an extended hospital stay while the surgical site heals and the care team confirms the device is functioning properly.²

Before discharge, patients and family members receive extensive training on driveline care, battery management, alarm response, and recognizing warning signs that require medical attention. This education is a critical part of the process, since patients leave the hospital responsible for the daily care of an implanted mechanical device.³

Risks and Complications

Bleeding is among the most common complications following VAD implantation, both during the immediate postoperative period and over the longer term, with gastrointestinal bleeding being particularly frequent due to changes in blood clotting factors caused by continuous flow circulation.⁴

Infection is another significant concern, most often centered around the driveline exit site where the cable passes through the skin. Because this connection is permanent, it creates an ongoing pathway for bacteria, and driveline infections can sometimes progress to more serious bloodstream infections if not treated promptly.⁴

Pump thrombosis, a blood clot forming within the device itself, can impair its function and increase stroke risk, while right heart failure can develop when the previously unsupported right ventricle struggles to keep pace with the newly improved output from the left side. Stroke, aortic valve dysfunction, and device malfunction round out the major risks that patients and care teams monitor closely throughout treatment.⁴

Living With a Ventricular Assist Device

Daily life with a VAD centers on a consistent routine: charging batteries, monitoring the controller display, keeping the driveline site clean and dry, and attending regular follow up appointments where the care team checks pump function and adjusts anticoagulation medication as needed.³

Many patients regain a meaningful degree of independence, returning to work, hobbies, and light exercise once they have recovered from surgery and adjusted to managing the equipment. Swimming and submerging the device are generally restricted, since the external components cannot be exposed to water, but many other activities remain possible with appropriate precautions.²

Ongoing anticoagulation therapy is standard for nearly all VAD patients to reduce the risk of clot formation within the pump, which means careful attention to bleeding risk becomes a permanent part of daily life, alongside the practical demands of keeping the device charged and functioning at all times.⁴

Outcomes and Prognosis

Survival with modern continuous flow VADs has improved substantially compared with earlier generation devices. Overall survival across VAD strategies is approximately 83 percent at one year, 76 percent at two years, and 54 percent at five years, though outcomes vary meaningfully by treatment goal.⁵

Patients implanted as a bridge to transplant tend to have better survival than those receiving destination therapy at every time point studied, with one year survival around 86 percent for bridge to transplant patients compared with roughly 72 percent for destination therapy patients.⁵ This gap likely reflects differences in age and underlying health between the two groups rather than a difference in the device itself.

A small subset of patients, roughly one to two percent, experience enough recovery of their own heart function that the device can eventually be removed. Researchers continue to study which patients are most likely to achieve this outcome, along with ongoing efforts to reduce complication rates through improved pump design and better anticoagulation strategies.⁶

Why Visual Communication Matters for Ventricular Assist Devices

A ventricular assist device is a genuinely complex piece of engineering working inside the body, and most patients have never seen anything like it before their diagnosis. Explaining how a magnetically levitated rotor moves blood, why a cable must permanently exit through the skin, or how the device fits alongside a heart that continues beating on its own requires visuals that most verbal explanations cannot achieve.¹

Medical device manufacturers, transplant centers, and patient education teams all depend on clear illustration and animation to explain candidacy criteria, surgical placement, daily device management, and the tradeoffs between bridge to transplant and destination therapy pathways.

• Illustrating how blood flows through the inflow cannula, pump, and outflow cannula back to the aorta
• Animating full magnetic levitation rotor technology and how it reduces clot risk
• Explaining the surgical placement of the device relative to the heart and major vessels
• Showing driveline routing and external component management for patient education
• Visualizing the differences between bridge to transplant, destination therapy, and bridge to recovery pathways
• Supporting clinical training on complication recognition and emergency response

How Biotic Artlab Supports Ventricular Assist Device Communication

We partner with device manufacturers, cardiac surgery programs, and life sciences companies to create visuals that make complex mechanical circulatory support technology understandable for clinicians, patients, and regulatory audiences alike.

• Custom 3D animations of VAD implantation and blood flow mechanics
• Detailed cutaway illustrations of pump components and rotor technology
• Patient education materials covering candidacy, surgery, and daily device management
• Clinical training content for surgical teams and VAD coordinators
• Regulatory and investor facing visuals explaining device mechanism of action
• Conference presentations and marketing materials for cardiac device audiences

Frequently Asked Questions

Is a ventricular assist device the same as an artificial heart?

No. A VAD works alongside the existing heart to help it pump more effectively, while a total artificial heart replaces the heart’s ventricles entirely. Most patients with a VAD retain their own heart, which continues to beat while the device provides additional support.¹

How long can someone live with a ventricular assist device?

Many patients live for years with a VAD, with roughly half of all recipients surviving to the five year mark across all treatment strategies. Bridge to transplant patients often go on to receive a donor heart, while destination therapy patients may remain on device support indefinitely.⁵

Can a person be removed from a ventricular assist device once implanted?

In a small percentage of cases, the heart recovers enough function that the device can be surgically removed, a pathway known as bridge to recovery. This outcome is uncommon but is an active area of research aimed at identifying which patients are most likely to experience it.⁶

What activities are restricted after receiving a VAD?

Swimming and any activity that would submerge the external equipment are generally restricted, since the controller and batteries cannot get wet. Many other activities, including light exercise, work, and travel, are possible once a patient has recovered from surgery and become comfortable managing the device.²

What is the biggest risk after VAD implantation?

Bleeding, infection at the driveline site, and pump thrombosis are among the most significant risks. Because most patients require lifelong anticoagulation to prevent clotting within the device, balancing clot prevention against bleeding risk is an ongoing part of VAD care.⁴

Why do some patients get a VAD instead of a heart transplant?

Not everyone with advanced heart failure qualifies for transplant due to age, other medical conditions, or limited donor organ availability. For these patients, a VAD can serve as destination therapy, a long term treatment intended to improve survival and quality of life without transplant.³

Have a Project in Mind? Contact Us.

If you are developing training materials, patient education content, or marketing visuals related to ventricular assist devices or mechanical circulatory support, our team can help translate the science into clear, accurate visuals. Contact us at info@biotic-artlab.com or get in touch through our contact form to discuss your project.

References

1. StatPearls, National Center for Biotechnology Information. Left Ventricular Assist Devices.
2. Johns Hopkins Medicine. Left Ventricular Assist Device (LVAD).
3. National Center for Biotechnology Information. The Role of Ventricular Assist Devices in Patients With Heart Failure Due to Dilated Cardiomyopathy, A Systematic Review.
4. National Center for Biotechnology Information. Thrombotic and Hemorrhagic Complications Following Left Ventricular Assist Device Placement.
5. National Center for Biotechnology Information. Outcomes of Left Ventricular Assist Devices as Destination Therapy, A Systematic Review With Meta Analysis.
6. National Center for Biotechnology Information. Left Ventricular Assist Device as a Bridge to Recovery for Patients With Advanced Heart Failure.

Disclaimer: This page provides general educational information and is not a substitute for diagnosis, treatment, emergency care, or individualized advice from a qualified healthcare professional.